← Back to Clinical Trials
Recruiting NCT06517407

NCT06517407 Para Versus Trans Rectus Stoma Placement for Prevention of Stoma Related Complications

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06517407
Status Recruiting
Phase
Sponsor Assiut University
Condition Stoma Malfunction
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2023-12-01
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2023-12-01 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Fecal divertion is a surgical procedure by which stoma is constructed through exteriorization of small intestine or large intestine(loop or end stoma).There are many indications for enterostomies such as malignancy, bleeding per rectum, MVO, Volvulus, iatrogenic colon injury, adhesive bands....... etc. Many factors concerning the operative technique are considered to influence the incidence of stoma related complications such as stoma prolapse, retraction, stenosis, para stomal herniation, para stomal soiling ,oedema and ileus. Site of stoma creation in relation to rectus abdominis muscle is believed to be one of them.

Eligibility Criteria

Inclusion Criteria: * All patient who recieve abdominal enterostomies either elective or emergencies in surgery department of assuit university hospital Exclusion Criteria: 1. Patient underwent repair of previous abdominal surgery 2. Patient known to have incisional or ventral abdominal hernia

Contact & Investigator

Central Contact

Amira Sayed Mohammed Sayed, Resident

✉ asmsda1996@gmail.Com

📞 01061434567

Frequently Asked Questions

Who can join the NCT06517407 clinical trial?

This trial is open to participants of all sexes, studying Stoma Malfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06517407 currently recruiting?

Yes, NCT06517407 is actively recruiting participants. Contact the research team at asmsda1996@gmail.Com for enrollment information.

Where is the NCT06517407 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT06517407 clinical trial?

NCT06517407 is sponsored by Assiut University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology